Related Experiment Video
Updated: Jul 14, 2026
Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets
Published on: October 3, 2014
Tissue engineering and stem cell therapy for myocardial repair
Yiping Gu1, Jiashing Yu, Lawrence G Lum
1University of California Berkeley and San Francisco Joint Bioengineering Graduate Group, USA.
Insights
Cardiovascular disease survivors often develop heart failure. Hybrid therapies combining tissue engineering with cell therapy show promise for myocardial repair, overcoming limitations of current treatments.
Area of Science:
- Regenerative Medicine
- Biomedical Engineering
- Cardiovascular Research
Background:
- Cardiovascular disease is a leading public health issue, with myocardial infarction frequently causing heart failure.
- Current treatments for end-stage heart failure are limited, with heart transplantation being the only definitive option.
- Existing cell therapies for myocardial repair face challenges in cell retention, survival, and differentiation, yielding inconsistent results.
Purpose of the Study:
- To review current advancements in cardiac tissue repair and engineering.
- To discuss emerging technologies for treating heart failure post-myocardial infarction.
- To explore hybrid therapeutic approaches for myocardial regeneration.
Main Methods:
- Review of preclinical and clinical studies on cell therapy for myocardial repair.
- Analysis of tissue engineering strategies for cardiac regeneration.
- Discussion of novel technologies in cardiac repair.
Main Results:
- Cell therapy alone has shown mixed results due to limitations in cell engraftment and function.
- Tissue engineering approaches offer potential for improved cardiac tissue regeneration.
- Hybrid therapies integrating tissue engineering and cell-based strategies are emerging as promising alternatives.
Conclusions:
- Limitations in current cell therapies necessitate novel approaches for myocardial repair.
- Tissue engineering combined with cell therapy represents a promising frontier for treating heart failure.
- Emerging technologies are crucial for advancing cardiac regenerative medicine.
Abstract:
Cardiovascular disease is a major public health problem in the United States. In many survivors, extensive tissue damage from myocardial infarction leads to the development of congestive heart failure. Unfortunately, thus far, heart transplantation has remained the only viable treatment for end-stage congestive heart failure. Lack of available donor hearts has thus led to search for alternative therapies. Among these, cell therapy has raised a great enthusiasm for myocardial repair. However, it suffers limitations associated with cell retention, survival and differentiation. In addition, the results from preclinical and clinical studies based on such treatments have generated mixed results. For this reason, hybrid therapies that incorporate tissue engineering are being developed as potentially new therapeutic approaches for repair of myocardial tissue. Here, we review the current progress in cardiac tissue repair and engineering; and discuss the new emerging technologies.
